跳至主要内容
临床试验/NCT02634138
NCT02634138终止不适用

Neuromuscular Electrical Stimulation in Patients With Critical Limb Ischaemia

Imperial College London2 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2015年11月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
4
试验地点
2
主要终点
Pain Score

研究概览

简要总结

This study will assess the benefit of a neuromuscular electrical stimulation device in patients suffering from symptoms and effects of critical limb ischaemia.

详细描述

The circulation of blood around the body is dependent on effective pumping of the heart. Patients with arterial insufficiency are known to have poor circulation in their lower legs and feet leading to various complications such as swelling and painful legs and reduced healing of injuries.

Peripheral arterial disease (PAD) can be defined as a narrowing of the arteries reducing blood flow. It is most commonly due to atherosclerosis, and has associations with heart disease, stroke, and diabetes. Its incidence is estimated at 7-14% in the general population, increasing with age to about 20% in the over-seventies. It is associated with effects on mobility, skin condition and quality of life. Symptoms include pain in the legs on walking (intermittent claudication), pain at rest (particularly at night), gangrene, and limb loss. Management of PAD is based on encouraging exercise, and modification of risk factors such as smoking, high blood pressure, high cholesterol and diabetes.

In patients with PAD, exercise tolerance is often limited. Severe symptoms and disease can be treated via such as balloon angioplasty, stenting or surgical bypass, but these procedures have risk. There also remains a percentage of patients who are not suitable for revascularisation, and have only a few options such as amputation available to them.

Some trials have shown that increasing the blood flow in the legs over time using medical devices (intermittent pneumatic compression, muscle stimulators), in addition to maximal medical and surgical therapy, can increase claudication distance, absolute walking distance, decrease rest pain, and reduce amputation rates. In the investigators unit it has become apparent that there are an increasing number of medical devices available for circulatory support, either as an inpatient, out-patient, or a member of the general public. The supporting evidence for these is variable in scientific and clinical content or relevance, and requires clinical trials to evaluate further.

Revitive activates the pumping action of leg muscles by providing electrical muscle stimulation to cause foot muscle contraction and relaxation which squeezes blood back towards the heart, improving circulation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Willing, able, and committed to participate in the procedures for the full length of the study.
  • All ethnic groups, male or female above the age of 18 years.
  • Diagnosis of non-reconstructable arterial disease and critical limb ischaemia (with a minimum of duplex ultrasound and an MDT discussion to have reached this diagnosis)
  • Be of non-childbearing potential; OR using adequate contraception and have a negative urine pregnancy test result within 24 hours if appropriate before using the study device.
  • Blood pressure currently under moderate control (< 160/100mmHg)
  • History of uncomplicated cardiovascular events beyond 3 months.
  • No current foot ulceration

排除标准

  • Patients meeting any of the following criteria are to be excluded:
  • Has an unstable condition (eg, psychiatric disorder, a recent history of substance abuse) or otherwise thought to be unreliable or incapable of complying with the study protocol.
  • Has any metal implants
  • Has peripheral neuropathy
  • Has a cardiac pacemaker or defibrillator device
  • Has recent lower limb injury or lower back pain
  • Has current foot ulceration or other skin ulcers
  • Has foot deformities
  • Has any disorder that, in the opinion of the Investigator, might interfere with the conduct of the study
  • Ankle-Brachial Pressure Index >0.9

研究组 & 干预措施

Intervention

Experimental

Revitive IX Neuromuscular Electrical Stimulation Device

干预措施: Revitive IX (Device)

结局指标

主要结局

Pain Score

时间窗: 6 weeks

Change in pain score with device use over a 6 week period. Measure by a visual analogue scale of pain with 0 = no pain and 10 = maximum pain

次要结局

  • Major amputation rate(6 weeks)
  • Femoral artery diameter(Day 1 and at 6 weeks)
  • Disease specific questionnaire - VascuQoL(Day 1 and at 6 weeks)
  • Short Form - 36 (SF-36)(Day 1 and at 6 weeks)
  • EuroQol - EQ5D(Day 1 and at 6 weeks)
  • Flow rate in Femoral Artery(Day 1 then at 6 weeks)
  • Patient compliance using diary of device use(6 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验